ASTERDM (Aster DM Healthcare Ltd.): Order Win
Aster DM Healthcare has received a certified true copy of the NCLT order sanctioning its Scheme of Amalgamation, according to an exchange filing dated 24 June. The company informed the NSE that the National Company Law Tribunal has approved the corporate restructuring, a regulatory milestone that typically consolidates operations under a unified entity.
Events like this—classified as order wins—have historically shown a 72% win rate across 50 comparable past instances, with a net edge of 1.6%, according to Strota's base rate data. This means similar regulatory approvals in the past have tended to correlate with positive short-term outcomes more often than not, though this is a statistical pattern across many stocks rather than a forecast for Aster DM specifically.
The stock closed at ₹769.7 on 24 June, up 0.5% from the previous session, trading 7.99% below its 52-week high of ₹836.5 and 48.28% above its 52-week low of ₹519.1. It remains above both its 50-day and 200-day moving averages. Relative volume at 0.84 indicates below-average trading activity. The company commands a market capitalisation of ₹39,789 crore, with a price-to-earnings ratio of 119.7 and return on equity of 10.1%.
What the data establishes is the completion of a regulatory step and the historical frequency of positive reactions to similar events. It does not establish whether this specific amalgamation will unlock value, nor does it account for integration execution risks or sector-specific factors that may influence outcomes.
The catalyst
Aster DM Healthcare Limited has informed the Exchange about receipt of certified true copy of the order of NCLT sanctioning Scheme of Amalgamation (filing · NSE)
What the data shows after this event
Across Strota's backtest of past filings, Order Win tends to continue — the move went bullish in about 72.0% of next sessions (net 1.6% after drift and cost, n=50). A base rate, not a forecast for this stock.
ASTERDM right now
trading +0.50% on the day; P/E 119.7; RSI 51.1. Full ASTERDM analysis →
Sources
- Aster DM Healthcare Limited has informed the Exchange about receipt of certified true copy of the order of NCLT sanctioning Scheme of Amalgamation — NSE
- Aster DM Healthcare Ltd subsidiary allots CCPS to investors via private placement — scanx.trade
- Aurobindo Pharma Ltd leads losers in 'A' group — Business Standard
- Number of shareholders of Aster DM Healthcare Ltd. – NSE:ASTERDM — TradingView
- How The Aster DM Healthcare (NSEI:ASTERDM) Narrative Is Shifting With New Valuation Assumptions — Simply Wall St.
Keep digging
- ASTERDM — full smart-money page: F&O positioning, deals, insider filings and option chain in one place.
- Today's screens: every stock matching the same setups (buildups, breakouts, volume shockers).
- Newsroom: the other stocks in play this session.